中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Mingyi LIANG)

1.Recent progress in application of local drug delivery for preventing restenosis after peripheral arterial revascularization.

Mingyi ZHANG ; Fuxian ZHANG ; Huan ZHANG ; Gangzhu LIANG

Chinese Journal of Surgery 2015;53(3):237-240

2.Hemostatic effect of non-insufflation intra-abdominal compression on liver injury

Bin LIANG ; Xiaoqiang HUANG ; Zhiqiang HUANG ; Mingyi CHEN ; Wenbin CHEN ; Lijie GAO ; Yanbin WANG ; Jiahong DONG

Chinese Journal of Trauma 2011;27(11):1045-1049

3.The distribution and related risk factors of femoro-popliteal artery chronic total occlusion lesions

Gangzhu LIANG ; Fuxian ZHANG ; Hailiang WEI ; Yongli DUAN ; Hui ZHAO ; Mingyi ZHANG ; Long CHENG

Journal of Interventional Radiology 2015;24(12):1052-1055

4.Comparison of temporomandibular joint injuries after three-dimensional conformal and intensity-modulated radiotherapies for nasopharyngeal carcinoma.

Dongping CHEN ; Yi YU ; Bin QI ; Jinquan LIU ; Mingyi LI ; Yuying LIANG

Journal of Southern Medical University 2012;32(7):991-994

5.Effect of ABCG5 and ABCG8 gene expression on formation of cholesterol gallstone and cholesterol polyp

Liang DENG ; Mingyi LIANG ; Kunsong ZHANG ; Fengfeng XU ; Wenfeng LI ; Jihong ZHANG

Chinese Journal of Hepatic Surgery(Electronic Edition) 2015;(2):125-128

6.Clinicopathological characteristics and prognostic factors of intrahepatic biliary cystadenocarcinoma.

Mingyue XU ; Xianjie SHI ; Tao WAN ; Hongguang WANG ; Lei HE ; Mingyi CHEN ; Yurong LIANG ; Jiahong DONG

Journal of Southern Medical University 2015;35(8):1097-1102

7.Treatment and prognosis of solid pseudopapillary neoplasms with metastases or recurrence.

Mingyue XU ; Xianjie SHI ; Email: SHIXIANJIE301@126.COM. ; Tao WAN ; Hongguang WANG ; Lei HE ; Mingyi CHEN ; Yurong LIANG ; Jiahong DONG

Chinese Journal of Surgery 2015;53(9):685-689

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO